Rhenman & Partners Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-68,000
| Closed | -$2.81M | – | 94 |
|
|
2023
Q3 | $2.81M | Sell |
68,000
-68,000
| -50% | -$2.81M | 0.3% | 66 |
|
|
2023
Q2 | $7.59M | Sell |
136,000
-14,000
| -9% | -$782K | 0.8% | 40 |
|
|
2023
Q1 | $7.81M | Buy |
150,000
+75,000
| +100% | +$3.9M | 0.86% | 38 |
|
|
2022
Q4 | $2.73M | Hold |
75,000
| – | – | 0.29% | 75 |
|
|
2022
Q3 | $2.04M | Buy |
+75,000
| New | +$2.04M | 0.21% | 85 |
|